Cite
HARVARD Citation
Wu, J. et al. (2021). Comparative cost-effectiveness of tildrakizumab and other commonly used treatments for moderate-to-severe psoriasis. Journal of dermatological treatment. pp. 693-700. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Wu, J. et al. (2021). Comparative cost-effectiveness of tildrakizumab and other commonly used treatments for moderate-to-severe psoriasis. Journal of dermatological treatment. pp. 693-700. [Online].